Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
OctoberDecember 2025: imlunestrant Imlunestrant, a next-generation, brain-penetrant, oral selective estrogen receptor degrader (SERD) by Eli Lilly, is awaiting FDA approval for patients with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer
Long-term creatine supplementation does not significantly affect clinical markers of health in athletes
You must click I understand, continue before you can proceed
Managing weight can be a significant challenge, particularly for men who face unique health challenges related to obesity
US$ 22.60
US$ 27.61
US$ 28.17
US$ 22.26
US$ 27.12
US$ 29.51
US$ 24.73
US$ 29.40
US$ 26.73
US$ 27.90
US$ 23.13
US$ 23.10
